Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Autors principals: Xiang Tong (Autor), Shijie Zhang (Autor), Dongguang Wang (Autor), Li Zhang (Autor), Jizheng Huang (Autor), Tianli Zhang (Autor), Hong Fan (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...